EirGenix, Inc. is Taiwan’s largest biologics CDMO, providing comprehensive services from cell line and process development to GMP manufacturing and analytical testing. With globally recognized quality systems and regulatory approvals, we deliver reliable biomanufacturing solutions to global partners.
Alongside our CDMO business, EirGenix is advancing its own biosimilar and ADC pipeline, focusing on antibody therapeutics for oncology and other diseases.
At EirGenix, Clients’ Success is Our Priority, and we strive to make innovative, high-quality biologics accessible worldwide.